Key points are not available for this paper at this time.
Design
Review
Authors
No takes yet. Share an insight, caveat, or question.
Does not alter hypertension management; leaves open refinement of renin-angiotensin system targets in future trials.
Edgar Haber (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: